BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26589942)

  • 1. PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.
    Wang W; Song XW; Bu XM; Zhang N; Zhao CH
    Cell Oncol (Dordr); 2016 Apr; 39(2):129-37. PubMed ID: 26589942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).
    Kou Y; Zhao Y; Bao C; Wang Q
    Cell Biochem Biophys; 2015 Jun; 72(2):571-8. PubMed ID: 25586720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death 2 protein induces gastric cancer cell growth arrest at the early S phase of the cell cycle and apoptosis in a p53-dependent manner.
    Zhang J; Wei W; Jin HC; Ying RC; Zhu AK; Zhang FJ
    Oncol Rep; 2015 Jan; 33(1):103-10. PubMed ID: 25334010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death 2 functions as a tumor suppressor in osteosarcoma.
    Yang Y; Jin Y; Du W
    Int J Clin Exp Pathol; 2015; 8(9):10894-900. PubMed ID: 26617804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor.
    Lu HJ; Yan J; Jin PY; Zheng GH; Qin SM; Wu DM; Lu J; Zheng YL
    Cancer Biomark; 2018 Feb; 21(3):711-722. PubMed ID: 29278883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of ETV1 and its contribution to tumorigenic phenotypes in gastrointestinal stromal tumors.
    Zhang Y; Gu ML; Zhou XX; Ma H; Yao HP; Ji F
    Oncol Rep; 2014 Sep; 32(3):927-34. PubMed ID: 24970355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
    Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
    Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis.
    Min KW
    Ultrastruct Pathol; 2010 May; 34(3):174-88. PubMed ID: 20455665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.
    Battaglia S; Maguire O; Thorne JL; Hornung LB; Doig CL; Liu S; Sucheston LE; Bianchi A; Khanim FL; Gommersall LM; Coulter HS; Rakha S; Giddings I; O'Neill LP; Cooper CS; McCabe CJ; Bunce CM; Campbell MJ
    Carcinogenesis; 2010 Sep; 31(9):1650-60. PubMed ID: 20466759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.
    Trent JC; Ramdas L; Dupart J; Hunt K; Macapinlac H; Taylor E; Hu L; Salvado A; Abbruzzese JL; Pollock R; Benjamin RS; Zhang W
    Cancer; 2006 Oct; 107(8):1898-908. PubMed ID: 16986125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
    Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
    PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of metallothionein in gastrointestinal stromal tumors and gastric carcinomas.
    Soo ET; Ng CT; Yip GW; Koo CY; Nga ME; Tan PH; Bay BH
    Anat Rec (Hoboken); 2011 Feb; 294(2):267-72. PubMed ID: 21235001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray analysis reveals distinct gene set profiles for gastric and intestinal gastrointestinal stromal tumors.
    Hara R; Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Hiramatsu Y; Kamiya K; Ohta M; Baba S; Konno H
    Anticancer Res; 2015 Jun; 35(6):3289-98. PubMed ID: 26026088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells.
    Dong Y; Liang C; Zhang B; Ma J; He X; Chen S; Zhang X; Chen W
    Cancer Lett; 2015 May; 361(1):137-46. PubMed ID: 25737303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells.
    Berglund E; Ubhayasekera SJ; Karlsson F; Akcakaya P; Aluthgedara W; Ahlen J; Fröbom R; Nilsson IL; Lui WO; Larsson C; Zedenius J; Bergquist J; Bränström R
    Anticancer Drugs; 2014 Apr; 25(4):415-22. PubMed ID: 24361761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-129-1-3p promote BGC-823 cell proliferation by targeting PDCD2.
    Du Y; Wang D; Luo L; Guo J
    Anat Rec (Hoboken); 2014 Dec; 297(12):2273-9. PubMed ID: 25111461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors.
    Setoguchi T; Kikuchi H; Yamamoto M; Baba M; Ohta M; Kamiya K; Tanaka T; Baba S; Goto-Inoue N; Setou M; Sasaki T; Mori H; Sugimura H; Konno H
    Cancer Sci; 2011 Apr; 102(4):883-9. PubMed ID: 21244575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.